Chun-Liang Lo

1.8k citations
38 papers · 1.5k indexed · h-index 22
Topics
Nanoparticle-Based Drug Delivery (28 papers)Nanoplatforms for cancer theranostics (22 papers)RNA Interference and Gene Delivery (7 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Chun-Liang Lo

37 papers receiving 1.5k citations

Peers

Chun-Liang Lo
Comparison fields: 5 of 96
  • Biomaterials 908
  • Biomedical Engineering 702
  • Molecular Biology 436
  • Organic Chemistry 301
  • Materials Chemistry 215
Replace Sang Mun Bae with:
Sang Mun Bae South Korea
Arun Kumar Mahanta India
Anbu Mozhi Singapore
Hyewon Ko South Korea
Kaimin Cai United States
Yoo-Shin Kim South Korea
Huaiyu Liu China
V. G. Deepagan South Korea
N. V. Nukolova Russia
Chun-Liang Lo relative to Sang Mun Bae South Korea Sang Mun Bae's profile →
Citations per field
00.5×1.5×1.9×
Sang Mun Bae · 1×
Citations per year

Countries citing papers authored by Chun-Liang Lo

Since Specialization
Citations

This map shows the geographic impact of Chun-Liang Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun-Liang Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun-Liang Lo more than expected).

Fields of papers citing papers by Chun-Liang Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun-Liang Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun-Liang Lo. The network helps show where Chun-Liang Lo may publish in the future.

Co-authorship network of co-authors of Chun-Liang Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Chun-Liang Lo. A scholar is included among the top collaborators of Chun-Liang Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun-Liang Lo. Chun-Liang Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 48
4 8
5 27
6 14
7 24
8 34
9 4
10 127
11 16
12 77
13 22
14 33
15 55
16 51
17 68
18 81
19 140
20 130

About Chun-Liang Lo

Chun-Liang Lo is a scholar working on Biomaterials, Biomedical Engineering and Pharmaceutical Science, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (28 papers), Nanoplatforms for cancer theranostics (22 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Biomaterials (908 citations), Molecular Medicine (147 citations) and Pharmaceutical Science (139 citations). Chun-Liang Lo has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Yi‐Ting Chiang, Ging-Ho Hsiue, Hsieh‐Chih Tsai, Ging‐Ho Hsiue, Yao Shen, Hsin‐Cheng Chiu, Yi‐Chun Chen, Tzu‐Chen Yen, Cheng-Hung Tsai and Tilahun Ayane Debele. Their work appears in journals such as ACS Nano, Biomaterials and Chemistry of Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026